Case 6 was a woman diagnosed with DLBCL (double expression of Bcl-2 and Myc) at the 117th month, with no adverse mutations found during NGS testing, and was alive by the endpoint of observation. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.